The Importance of an NCI SPORE Grant

Jeffrey S. Weber, MD, PhD
Published Online: October 31, 2013
Jeffrey S. Weber, MD, PhD, medical oncologist, Department of Cutaneous Oncology, director, Donald A. Adam Comprehensive Melanoma Research Center, Moffitt Cancer Center, comments on the importance of a Specialized Programs of Research Excellence (SPORE) grant.

Clinical Pearls

  • A Specialized Programs of Research Excellence (SPORE) grant is given out by the NCI
  • SPORE grants bring together investigators from all different disciplines focused on one histology
  • As a part of the SPORE grant given to Moffitt Cancer Center, each project has preclinical laboratory pieces leading to a clinical trial
  • Two out of three SPORE projects at Moffitt currently have clinical trials ongoing

Related Articles
Treatment with nivolumab (Opdivo) demonstrated superior objective response rates (ORR) and longer durations of response compared with chemotherapy in a phase III trial of patients with previously treated advanced metastatic melanoma
The FDA has assigned a priority review designation to nivolumab for pretreated patients with advanced melanoma, setting an action date for the drug as March 30, 2015.
Stand Up To Cancer (SU2C) recently announced the launch of a new Ovarian Cancer Dream Team.
Lawrence Fong, MD, discusses the systemic antitumor effect and clinical response in a phase II trial of intratumoral electroporation of plasmid interleukin-12 (IL-12) in patients with advanced melanoma.
JTT Articles
CD19-Targeted Agents Continue to Show Positive Outcomes
Graft Versus Host Disease for the General Oncologist
A Long-Awaited Treatment Option for Radioiodine- Refractory DTC
External Resources

Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Internal Resources

Targeted Communications
Connect With Us:

About Us
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright TargetedOnc 2013
Intellisphere, LLC. All Rights Reserved.